首页> 外文期刊>European journal of ophthalmology >Meta-analysis of the concordance of Icare ? PRO–based rebound and Goldmann applanation tonometry in glaucoma patients
【24h】

Meta-analysis of the concordance of Icare ? PRO–based rebound and Goldmann applanation tonometry in glaucoma patients

机译:Meta分析ICare的一致性? 基于Pro的反弹和Golaucoma患者的普罗旺斯施防纯度

获取原文
获取原文并翻译 | 示例
       

摘要

Background: The Icare~(?)PRO rebound tonometer is being promoted as a patient-friendly device for glaucoma detection and monitoring, allowing rapid and accurate intraocular pressure measurement avoiding anaesthesia. The aim of this systematic review was to examine the concordance of Icare~(?)PRO and Goldmann applanation tonometry in glaucoma patients. Methods: The German and English literature research was carried out using PubMed and Cochrane Library between January 2010 and March 2018. Method comparison trials in a paired sample study design were identified. Search criteria were ‘Icare PRO’, ‘Rebound’, ‘Goldmann’ and ‘Applanation’. Adult patients with glaucoma of any aetiology were included. The intraindividual intraocular pressure deviation between Icare~(?)PRO and Goldmann applanation tonometry (mm Hg) served as primary endpoint, parameterized by the reported mean differences. For each study, an asymptotic 95% confidence interval was derived. The overall intraocular pressure meta-difference (Icare~(?)PRO-Goldmann applanation tonometry) and 95% confidence interval were estimated using the random effect model. Result: Of 147 publications, 6 studies (672 eyes) were included after reviewing. Four studies showed an intraocular pressure underestimation by the Icare~(?)PRO, two an overestimation. The meta-difference (Icare~(?)PRO-Goldmann applanation tonometry = ?0.14 mm Hg; 95% confidence interval: (?0.43 mm Hg; 0.15 mm Hg)) indicated a non-significant, clinically irrelevant mean deviation (p = 0.335). The devices showed good agreement, but there was a strong heterogeneity between the studies (I2 = 77%): two studies presented a significant difference (Icare~(?)PRO-Goldmann applanation tonometry), however, with deviations in opposite directions. Conclusion: Although the manufacturer advertises the Icare~(?)PRO as a ‘tonometer with superior accuracy’, the present review could neither confirm nor deny considerable agreement between Goldmann applanation tonometry and Icare~(?)PRO in glaucomatous patients.
机译:背景:icare〜(?)Pro反弹Tonometer正在推广作为患者友好的青光眼检测和监测装置,允许快速准确的眼内压力测量避免麻醉。这种系统审查的目的是审查ICare〜(?)Pro和Goldmann施加型术中的冰淇淋患者的一致性。方法:在2010年1月至2018年3月之间使用PubMed和Cochrane图书馆进行了德语和英语文学研究。确定了配对样本研究设计中的方法比较试验。搜索条件是'ICare Pro','反弹','Goldmann'和'Applanation'。包括任何Aetiology的青光眼的成年患者。 ICare〜(?)Pro与Goldmann施加正统(MM HG)之间的内部内部偏差偏离(MM HG)作为主要终点,通过报告的平均差异参数化。对于每项研究,衍生渐近95%置信区间。使用随机效应模型估算了整体眼压元差(ICare〜(?)替代〜(Δ)促合理置信区规)和95%置信区间。结果:147个出版物,审查后,纳入6项研究(672只眼)。四项研究表明,ICare〜(?)Pro低估了眼压尺寸,两次高估。荟萃差异(ICare〜(?)Pro-goldmann施孔Tononetry =?0.14 mm Hg; 95%置信区间:(?0.43mm Hg; 0.15 mm Hg))指示非显着,临床上无关的平均偏差(P = 0.335)。该器件表现出良好的一致性,但研究之间存在强烈的异质性(I2 = 77%):两项研究呈现出显着差异(ICare〜(?)Pro-goldmann施加编音学),但是,偏离方向偏差。结论:虽然制造商宣布了ICare〜(?)PRO作为“具有卓越准确性”的“Tonometer”,但本综述既不会确认,在Glaucomatous患者中,Goldmann Applanation Tonoxatrationry和ICare〜(?)Pro之间也不是相当大的协议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号